**Sponsored by Interactive Offers, LLC
Healthcare Triangle Subsidiary QuantumNexis Reports $20M in Consumption-Based Revenue Processed on Ezovion Platform, Forecasts $37M Amid Rapid Growth
Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025
A fast-moving company at the center of healthcare’s cloud and AI transformation — backed by real contracts, real margins, and real momentum
__________________________________
Hello Everyone,
We have a time sensitive situation that we want you to be aware of ahead of today’s session. I say “time sensitive” because the company had a major even that JUST took place. Get HCTI on your screen before you do anything else.
The company just effected a reverse stock split that reduced the Company’s number of shares outstanding from approximately 45,417,091 all the way down to approximately 756,952 shares. We often see companies take a hit when word gets out and we just saw HCTI down for 9 sessions in a row but the bleeding appears to have slowed down.
Finviz says there are 180k shares in the float. Even if that is close to accurate we are dealing with a nano-float.
HCTI is no stranger to going on strong runs in the past and with the companies new structure in place and those looking at this one right now are in the forefront with the ink barely dry on last weeks announcement that foretold of Tuesday’s split.
HCTI is already generating substantial revenues and if you take peak at the companies newsfeed you will see that the pot is about to get a little bit sweeter in the future with numberThe healthcare system is undergoing one of the most disruptive technology shifts in history, and Healthcare Triangle (NASDAQ: HCTI) is rapidly aligning itself with where the industry is headed.
Hospitals and providers are racing to deploy AI to eliminate inefficiencies, automate workflows, and improve patient outcomes — and HCTI’s AI-first strategy places it directly in that demand stream.
Through its QuantumNexis platform, HITRUST-certified cloud solutions, and expanding SaaS offerings, HCTI is transitioning toward higher-margin, recurring revenue at a time when global healthcare AI adoption is accelerating sharply.
Zacks Small Cap Research has taken notice, emphasizing that HCTI is well positioned to benefit as providers increasingly turn to AI to drive operational efficiency.
That thesis gained real weight with HCTI’s planned acquisition of Teyame.AI, a fast-growing AI engagement company expected to deliver $34 million in annual revenue. Teyame’s agentic generative AI, multilingual chatbot automation, and omnichannel engagement capabilities — already proven in regulated industries and piloting in healthcare — could instantly elevate HCTI into a global digital health engagement leader.
Combined with HCTI’s existing hospital intelligence, EHR, and mental health platforms, this move expands total addressable market, accelerates international growth, and positions HCTI for a potential step-change in scale — all while analysts’ revenue forecasts have yet to include any contribution from the deal.
Healthcare Triangle, Inc., based in Pleasanton, California, drives digital transformation for healthcare and life sciences organizations through advanced cloud, data, and AI solutions. The company serves hospitals, health systems, payers, and pharmaceutical/life sciences enterprises with technology designed to enhance clinical efficiency and operational performance.
By helping organizations improve health outcomes through optimized use of data and information technologies, Healthcare Triangle plays a critical role in digital transformation across the healthcare ecosystem. The company’s Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™, has achieved HITRUST Risk-based, 2-year (r2) Certified status—an industry-recognized benchmark for data protection and information security.
Healthcare Triangle enables the adoption of emerging technologies, supports data-driven decision-making, and facilitates agility in response to business demands and market pressures. With the addition of QuantumNexis, the company has further expanded its reach into AI-powered SaaS solutions that support mental health, hospital automation, and intelligent clinical workflows.
With a focus on compliance, interoperability, and emerging technologies, Healthcare Triangle remains a trusted partner for highly regulated healthcare and life sciences sectors worldwide.
Healthcare Triangle is entering its next phase of growth with clear momentum across its AI-driven SaaS platforms and growing opportunities in both the U.S. and international markets. Together, the EHR, healthcare cloud, and AI segments represent a combined $128B+ market opportunity, creating a robust backdrop for HCTI’s long-term growth potential.
QuantumNexis has already processed about $20 million in revenue through the Ezovion platform, with visibility toward $37 million in the near term—giving investors an early look at the platform’s scaling potential.
The U.S. launch of Ziloy, Ezovion’s inclusion on the Microsoft Azure Marketplace, and new global partnerships are broadening reach and strengthening confidence in future revenue.
Alongside new health-system contract wins, the expansion of HCTI’s AI-powered EHR services, and a strategic pipeline that now includes a non-binding LOI to acquire Teyame.AI, the company is setting the stage for more scalable, recurring, and diversified revenue growth ahead.
Why Look at HCTI Right Now
Strategic Expansion into Gen AI Healthcare SaaS: Healthcare Triangle, Inc. has launched a dedicated AI subsidiary, aligning with high-growth generative AI applications in healthcare.
Exposure to Multi-Trillion Dollar Market Trends: Active in segments projected to exceed $2.3 trillion by 2034, including digital health, AI, cloud computing, and analytics.
HITRUST Certified Platforms: CloudEz™ and DataEz™ platforms are HITRUST r2 certified, demonstrating strong data protection and compliance standards.
Recent Strategic Acquisitions: Acquisitions of Niyama and Ezovion strengthen capabilities in mental health SaaS and hospital intelligence systems.
Strong Customer Traction: Solutions deployed in over 325 hospitals across Asia and MEA, supporting proven scalability.
Recurring Revenue Model: Growing shift toward SaaS-based offerings supports predictable, high-margin revenue streams.
Global Partnership Ecosystem: Collaborations with AWS, Microsoft Azure, Google Cloud, and other major platforms enhance technological reach and reliability.
Focused Cost Optimization Plan: Ongoing enterprise-wide initiative targeting $1.8 million in annualized savings to improve operational efficiency.
Healthy Balance Sheet: HCTI holds more cash than total debt, reflecting a prudent financial structure and lower leverage risk.
Positioned for Global Digital Health Demand: With expansion into Southeast Asia and beyond, HCTI is aligned with rising international demand for digital healthcare modernization.
Healthcare Triangle Inc. subsidiary QuantumNexis Announce Joint Venture with Golden Code Holdings to Accelerate AI and Digital Health Transformation in Saudi Arabia
This Joint Venture strengthens Healthcare Triangle’s and QuantumNexis’ position to access the fastest growing Saudi Arabia 70-billion-dollar Healthcare Market by 2030
PLEASANTON, Calif., Feb. 5, 2026 /PRNewswire/ — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that its subsidiary QuantumNexis is participating a Joint Venture with Golden Code Holdings to address the 70 Billion US dollar Healthcare Market by 2030 and align with the Saudi Arabian Kingdom’s rapidly advancing healthcare transformation agenda.
This Joint Venture brings together QuantumNexis’ global expertise in AI‑powered healthcare platforms and open standards with Golden Code Holdings’ strong local presence, investment capability, and deep understanding of the Saudi market. It will play a pivotal role in supporting Saudi Vision 2030, the Ministry of Health’s digital strategy, and the Kingdom’s ambition to build a world‑leading, interoperable, and data‑driven healthcare ecosystem and shifting towards value-based care, focusing on patient outcomes rather than volume.
Driving National‑Scale Digital Health Modernization
The QuantumNexis Team will introduce a unified suite of advanced digital health platforms in Saudi Arabia, including:
- Ezovion — a next‑generation hospital and clinical operations platform
- Ziloy.ai — AI‑powered clinical and operational intelligence
- Readabl.ai — automation and documentation intelligence for care teams
- openEHR ‑ based interoperability solutions through global partnerships with Better.care and Microsoft.
These solutions will support hospitals, clinics, and enterprise healthcare groups in modernizing workflows, improving care coordination, and enabling real‑time insights across the continuum of care.
Aligned with Saudi Arabia’s Vision 2030
The Joint Venture is designed to advance key national priorities by:
- Deploying open standards and interoperable platforms across health systems
- Enabling AI‑driven decision support, predictive analytics, and operational optimization
- Building a Saudi‑based digital health workforce through capability development programs
- Supporting localization, compliance, and long‑term sustainability
- Establishing a regional hub for innovation, research, and co‑development
David Ayanoglou, Chief Financial Officer of HCTI said, “We are excited to be part of this large project which will have aim to have large impacts on patient outcomes and will proliferate the deployment of our offerings in the region”.
Kathir K., President & Chief Growth Officer, QuantumNexis, said, “Our joint venture with Golden Code Holdings marks a defining moment in our global expansion. Saudi Arabia is shaping the future of healthcare, and together we are building a standards‑driven, AI‑powered ecosystem that empowers providers, strengthens national capabilities, and delivers measurable outcomes for patients across the Kingdom.”
Mustafa Razza, Director of Growth, Golden Code Holdings, added, “Partnering with QuantumNexis and HCTI aligns with our commitment to bring world‑class digital health innovation to Saudi Arabia. This joint venture will accelerate the Kingdom’s transition to interoperable, data‑driven healthcare and create new opportunities for local talent and technology leadership.”
A Regional Hub for Digital Health Innovation
QuantumNexis presence in Saudi Arabia will serve as the company’s Middle East hub, supporting:
- Government health programs
- Private hospital groups
- Enterprise healthcare networks
- Academic and research collaborations
- Workforce development initiatives
The Joint Venture will also drive co‑innovation with global partners to bring advanced AI, automation, and interoperability solutions to the region.
About Healthcare TriangleHealthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.
About Quantum Nexis
Quantum Nexis is a global digital health ecosystem focused on AI‑powered platforms, interoperability, and healthcare modernization. Through its multi‑brand portfolio and strategic partnerships, the company supports hospitals, clinics, and health systems across Asia, the Middle East, Africa, and Europe.
About Golden Code Holdings
Golden Code Holdings is a Saudi‑based technology and investment group with deep expertise in digital transformation, enterprise solutions, and national‑scale technology programs. The company partners with global innovators to bring advanced solutions to the Kingdom.
MANAGEMENT
- Dave Rosa
- Chairman of the Board
- Dave Rosa is the Chairman of the Board of Directors; and is a member of our Board of Directors since August 2021. He is also the President and CEO of NeuroOne Medical Technologies, a publicly traded company. He also serves on the boards of Biotricity a publicly traded company. Mr. Rosa has over 25 years of experience in holding a variety of senior management roles across several medical device markets.
- Ronald McClurg
- Member of the Board
- Mr. McClurg has over 30 years of financial leadership experience with public and private companies. Mr. McClurg has served as CFO of NeuroOne Medical Technologies Corp. (Nasdaq: NMTC) since January 2021. Prior to joining NeuroOne, from 2003 to 2019, Mr. McClurg served as VP – Finance and CFO of Incisive Surgical, Inc. Prior to 2003, Mr. McClurg served as CFO of Wavecrest Corporation, Video Sentry Corporation, Insignia Systems, Inc. (Nasdaq: ISIG), and Orthomet, Inc. Currently, he serves on the board of governors of Biomagnetic Sciences, LLC and serves as a director and audit committee chair for Biotricity, Inc. (Nasdaq: BTCY).
- Jainal Bhuiyan
- Member of the Board
- Jainal is currently a Senior Managing Director in investment banking at Paulson Investment Company. Prior to Paulson, he was a partner at HRA Capital, a boutique investment bank he co-founded in 2012 . Over the course of his 18 years of healthcare investment banking and capital markets experience, he has advised private and public healthcare companies from start-ups to commercially mature enterprises, totaling more than $3B in transactions. He holds FINRA Series 7, Series 63, and Series 79 licenses.
- Sujatha Ramesh
- Chief Operating Officer & Board Director
- Sujatha Ramesh is the Chief Operating Officer and Board Director of Healthcare Triangle Inc., where she leads operational strategy, sales, customer success, delivery, HR, governance, and financial planning. She also serves as the Chief Operating Officer of HCTI’s subsidiary company, providing hands-on leadership in scaling operations and delivery. Sujatha plays a key role in mergers and acquisitions, supporting strategic growth and integration initiatives.
- With over 25 years of global leadership experience in financial services and technology, she has led enterprise-wide transformations across the Americas, Europe, and Asia. Sujatha brings deep expertise in operational strategy, corporate growth, technology modernization, regulatory compliance, and risk management. She has managed budgets exceeding $250 million and delivered over $112 million in value through strategic transformation and operational efficiency.
- She previously held senior roles at Citigroup, Publicis Sapient, Infinite Computer Solutions, and Capgemini (iGATE Global Solutions).
- Sujatha brings a powerful combination of operational expertise, governance insight, strategic foresight, and global execution excellence to HCTI’s boardroom—further strengthening the Company’s leadership as it drives global expansion and transformation.
NEWS
Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan
5 days ago
6 days ago
Jan 29, 2026
Jan 28, 2026
Jan 23, 2026
Jan 22, 2026
Dec 10, 2025
Nov 24, 2025
Healthcare Triangle’s Strategic Intent Rewarded with a 32% Share Gain Since September (NASDAQ:HCTI)
Oct 14, 2025
Healthcare Triangle Plays Offense to Redefine What Aggressive Growth Looks Like (NASDAQ: HCTI)
Oct 13, 2025
Oct 10, 2025
Healthcare Triangle, a $16M Microcap, Targets Teyame.AI and Its $34M FY2025 (NASDAQ: HCTI)
Oct 10, 2025
Oct 9, 2025
Oct 8, 2025
Oct 8, 2025
Oct 8, 2025
Oct 3, 2025
Oct 3, 2025
Oct 3, 2025
Oct 2, 2025
SINCERELY,
DISCLAIMER
THIS WEBSITE/NEWSLETTER IS OWNED SUBSIDIARY BY DEDICATED INVESTORS, LLC.
OUR REPORTS/RELEASES ARE A COMMERCIAL ADVERTISEMENT AND ARE FOR GENERAL INFORMATION PURPOSES ONLY. WE ARE ENGAGED IN THE BUSINESS OF MARKETING AND ADVERTISING COMPANIES FOR MONETARY COMPENSATION. WE HAVE BEEN COMPENSATED A FEE OF FIFTEEN THOUSAND USD BY INTERACTIVE OFFERS LLC FOR A ONE DAY HCTI AWARENESS CAMPAIGN. NEVER INVEST IN ANY STOCK FEATURED ON OUR SITE OR EMAILS UNLESS YOU CAN AFFORD TO LOSE YOUR ENTIRE INVESTMENT. THE DISCLAIMER IS TO BE READ AND FULLY UNDERSTOOD BEFORE USING OUR SERVICES, JOINING OUR SITE OR OUR EMAIL/BLOG LIST AS WELL AS ANY SOCIAL NETWORKING PLATFORMS WE MAY USE.PLEASE NOTE WELL: DEDICATED INVESTORS LLC AND ITS EMPLOYEES ARE NOT A REGISTERED INVESTMENT ADVISOR, BROKER DEALER OR A MEMBER OF ANY ASSOCIATION FOR OTHER RESEARCH PROVIDERS IN ANY JURISDICTION WHATSOEVER.RELEASE OF LIABILITY: THROUGH USE OF THIS WEBSITE VIEWING OR USING YOU AGREE TO HOLD DEDICATED INVESTORS LLC, ITS OPERATORS OWNERS AND EMPLOYEES HARMLESS AND TO COMPLETELY RELEASE THEM FROM ANY AND ALL LIABILITY DUE TO ANY AND ALL LOSS (MONETARY OR OTHERWISE), DAMAGE (MONETARY OR OTHERWISE), OR INJURY (MONETARY OR OTHERWISE) THAT YOU MAY INCUR. THE INFORMATION CONTAINED HEREIN IS BASED ON SOURCES WHICH WE BELIEVE TO BE RELIABLE BUT IS NOT GUARANTEED BY US AS BEING ACCURATE AND DOES NOT PURPORT TO BE A COMPLETE STATEMENT OR SUMMARY OF THE AVAILABLE DATA. DEDICATED INVESTORS LLC ENCOURAGES READERS AND INVESTORS TO SUPPLEMENT THE INFORMATION IN THESE REPORTS WITH INDEPENDENT RESEARCH AND OTHER PROFESSIONAL ADVICE. ALL INFORMATION ON FEATURED COMPANIES IS PROVIDED BY THE COMPANIES PROFILED, OR IS AVAILABLE FROM PUBLIC SOURCES AND DEDICATED INVESTORS LLC MAKES NO REPRESENTATIONS, WARRANTIES OR GUARANTEES AS TO THE ACCURACY OR COMPLETENESS OF THE DISCLOSURE BY THE PROFILED COMPANIES. NONE OF THE MATERIALS OR ADVERTISEMENTS HEREIN CONSTITUTE OFFERS OR SOLICITATIONS TO PURCHASE OR SELL SECURITIES OF THE COMPANIES PROFILED HEREIN AND ANY DECISION TO INVEST IN ANY SUCH COMPANY OR OTHER FINANCIAL DECISIONS SHOULD NOT BE MADE BASED UPON THE INFORMATION PROVIDED HEREIN. INSTEAD DEDICATED INVESTORS LLC STRONGLY URGES YOU CONDUCT A COMPLETE AND INDEPENDENT INVESTIGATION OF THE RESPECTIVE COMPANIES AND CONSIDERATION OF ALL PERTINENT RISKS. READERS ARE ADVISED TO REVIEW SEC PERIODIC REPORTS: FORMS 10-Q, 10K, FORM 8-K, INSIDER REPORTS, FORMS 3, 4, 5 SCHEDULE 13D.DEDICATED INVESTORS LLC IS COMPLIANT WITH THE CAN SPAM ACT OF 2003. DEDICATED INVESTORS LLC DOES NOT OFFER SUCH ADVICE OR ANALYSIS, AND DEDICATED INVESTORS LLC FURTHER URGES YOU TO CONSULT YOUR OWN INDEPENDENT TAX, BUSINESS, FINANCIAL AND INVESTMENT ADVISORS. INVESTING IN MICRO-CAP AND GROWTH SECURITIES IS HIGHLY SPECULATIVE AND CARRIES AND EXTREMELY HIGH DEGREE OF RISK. IT IS POSSIBLE THAT AN INVESTORS INVESTMENT MAY BE LOST OR IMPAIRED DUE TO THE SPECULATIVE NATURE OF THE COMPANIES PROFILED.THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 PROVIDES INVESTORS A SAFE HARBOR IN REGARD TO FORWARD-LOOKING STATEMENTS. ANY STATEMENTS THAT EXPRESS OR INVOLVE DISCUSSIONS WITH RESPECT TO PREDICTIONS, EXPECTATIONS, BELIEFS, PLANS, PROJECTIONS, OBJECTIVES, GOALS, ASSUMPTIONS OR FUTURE EVENTS OR PERFORMANCE ARE NOT STATEMENTS OF HISTORICAL FACT MAY BE FORWARD LOOKING STATEMENTS. FORWARD LOOKING STATEMENTS ARE BASED ON EXPECTATIONS, ESTIMATES, AND PROJECTIONS AT THE TIME THE STATEMENTS ARE MADE THAT INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM THOSE PRESENTLY ANTICIPATED. FORWARD LOOKING STATEMENTS IN THIS ACTION MAY BE IDENTIFIED THROUGH USE OF WORDS SUCH AS PROJECTS, FORESEE, EXPECTS, WILL, ANTICIPATES, ESTIMATES, BELIEVES, UNDERSTANDS, OR THAT BY STATEMENTS INDICATING CERTAIN ACTIONS & QUOTE; MAY, COULD, OR MIGHT OCCUR. UNDERSTAND THERE IS NO GUARANTEE PAST PERFORMANCE WILL BE INDICATIVE OF FUTURE RESULTS. IN PREPARING THIS PUBLICATION, DEDICATED INVESTORS LLC HAS RELIED UPON INFORMATION SUPPLIED BY ITS CUSTOMERS, PUBLICLY AVAILABLE INFORMATION AND PRESS RELEASES WHICH IT BELIEVES TO BE RELIABLE; HOWEVER, SUCH RELIABILITY CANNOT BE GUARANTEED. INVESTORS SHOULD NOT RELY ON THE INFORMATION CONTAINED IN THIS WEBSITE. RATHER, INVESTORS SHOULD USE THE INFORMATION CONTAINED IN THIS WEBSITE AS A STARTING POINT FOR DOING ADDITIONAL INDEPENDENT RESEARCH ON THE FEATURED COMPANIES. THE ADVERTISEMENTS IN THIS WEBSITE ARE BELIEVED TO BE RELIABLE, HOWEVER, DEDICATED INVESTORS LLC AND ITS OWNERS, AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, REPRESENTATIVES AND AGENTS DISCLAIM ANY LIABILITY AS TO THE COMPLETENESS OR ACCURACY OF THE INFORMATION CONTAINED IN ANY ADVERTISEMENT AND FOR ANY OMISSIONS OF MATERIALS FACTS FROM SUCH ADVERTISEMENT. DEDICATED INVESTORS LLC IS NOT RESPONSIBLE FOR ANY CLAIMS MADE BY THE COMPANIES ADVERTISED HEREIN, NOR IS DEDICATED INVESTORS LLC RESPONSIBLE FOR ANY OTHER PROMOTIONAL FIRM, ITS PROGRAM OR ITS STRUCTURE. DEDICATED INVESTORS LLC IS NOT AFFILIATED WITH ANY EXCHANGE, ELECTRONIC QUOTATION SYSTEM, THE SECURITIES EXCHANGE COMMISSION OR FINRA.